Studies on sustained-release suppositories. III. Rectal absorption of morphine in rabbits and prolongation of its absorption by alginic acid addition.
Rectal absorption of morphine from various kinds of suppository bases was investigated. The extent of bioavailability of morphine by rectal administration varied with the bases used (30.5-97.5%), but every value was higher than that in the case of oral administration (13.5%). Witepsol bases were preferable to macrogol base for the rectal absorption of morphine. In particular, Witepsol S-55 or W-35 gave a higher plasma peak level than H-15 or E-75, whereas the difference in the mean residence times obtained from these bases could not be regarded as significant. Sustained-release suppositories of morphine could be prepared simply by mixing alginic acid (Alg) with morphine in a suppository base. Further, prolonged rectal absorption could be obtained by using these sustained-release suppositories, and the absorption rate was controlled by the amount of Alg added. It seems likely that the sustained release was due to the binding of morphine to Alg from the results of partition coefficient and binding ratio measurements in aqueous solution. The rapid initial absorption and the subsequent prolonged absorption of morphine simultaneously obtained from the morphine-Alg suppository may be useful in the clinical context.
Kawashima
S
S
School of Pharmacy, Hokuriku University, Kanazawa, Japan.
Inoue
Y
Y
Shimeno
T
T
Fujiwara
H
H
D000464:Alginates / Q000494:pharmacology*; D000818:Animals; D003692:Delayed-Action Preparations; D020723:Glucuronic Acid; D006603:Hexuronic Acids; D007408:Intestinal Absorption / Q000187:drug effects*; D008297:Male; D009020:Morphine / Q000008:administration & dosage / Q000493:pharmacokinetics*; D011817:Rabbits; D012007:Rectum / Q000187:drug effects / Q000378:metabolism; D013488:Suppositories
D000464:Alginates; D003692:Delayed-Action Preparations; D006603:Hexuronic Acids; D013488:Suppositories; D009020:Morphine; D020723:Glucuronic Acid